Jens Lipka

3.0k total citations · 1 hit paper
13 papers, 2.4k citations indexed

About

Jens Lipka is a scholar working on Materials Chemistry, Pulmonary and Respiratory Medicine and Health, Toxicology and Mutagenesis. According to data from OpenAlex, Jens Lipka has authored 13 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Materials Chemistry, 5 papers in Pulmonary and Respiratory Medicine and 4 papers in Health, Toxicology and Mutagenesis. Recurrent topics in Jens Lipka's work include Nanoparticles: synthesis and applications (5 papers), Nanoparticle-Based Drug Delivery (4 papers) and Inhalation and Respiratory Drug Delivery (4 papers). Jens Lipka is often cited by papers focused on Nanoparticles: synthesis and applications (5 papers), Nanoparticle-Based Drug Delivery (4 papers) and Inhalation and Respiratory Drug Delivery (4 papers). Jens Lipka collaborates with scholars based in Germany, Italy and Australia. Jens Lipka's co-authors include Wolfgang G. Kreyling, Manuela Semmler‐Behnke, Alexander Wenk, Carsten Schleh, Günter Schmid, Shinji Takenaka, Martin Schäffler, Stephanie Hirn, Ulrich Simon and Winfried Möller and has published in prestigious journals such as ACS Nano, Biomaterials and Small.

In The Last Decade

Jens Lipka

13 papers receiving 2.4k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Particle size-dependent and surface charge-dependent biodistribution of gold nanoparticles after intravenous administration

2011 473 citations Stephanie Hirn, Manuela Semmler‐Behnke et al. European Journal of Pharmaceutics and Biopharmaceutics profile →

Peers

Countries citing papers authored by Jens Lipka

Since Specialization

Citations

This map shows the geographic impact of Jens Lipka's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jens Lipka with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jens Lipka more than expected).

Fields of papers citing papers by Jens Lipka

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jens Lipka. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jens Lipka. The network helps show where Jens Lipka may publish in the future.

Co-authorship network of co-authors of Jens Lipka

This figure shows the co-authorship network connecting the top 25 collaborators of Jens Lipka. A scholar is included among the top collaborators of Jens Lipka based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jens Lipka. Jens Lipka is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

#	Work	Indexed citations
1	Quantitative biokinetics of titanium dioxide nanoparticles after oral application in rats: Part 2 2017 ·Nanotoxicology ·Wolfgang G. Kreyling, Uwe Holzwarth, Carsten Schleh, Ján Kozempel, Alexander Wenk, Nadine Haberl, Stephanie Hirn, Martin Schäffler, Jens Lipka, Manuela Semmler‐Behnke, P.N. Gibson	107
2	Quantitative biokinetics of titanium dioxide nanoparticles after intratracheal instillation in rats: Part 3 2017 ·Nanotoxicology ·Wolfgang G. Kreyling, Uwe Holzwarth, Nadine Haberl, Ján Kozempel, Alexander Wenk, Stephanie Hirn, Carsten Schleh, Martin Schäffler, Jens Lipka, Manuela Semmler‐Behnke, P.N. Gibson	63
3	Quantitative biokinetics of titanium dioxide nanoparticles after intravenous injection in rats: Part 1 2017 ·Nanotoxicology ·Wolfgang G. Kreyling, Uwe Holzwarth, Nadine Haberl, Ján Kozempel, Stephanie Hirn, Alexander Wenk, Carsten Schleh, Martin Schäffler, Jens Lipka, Manuela Semmler‐Behnke, P.N. Gibson	64
4	Biokinetic studies of non-complexed siRNA versus nano-sized PEI F25-LMW/siRNA polyplexes following intratracheal instillation into mice 2016 ·International Journal of Pharmaceutics ·Jens Lipka, Manuela Semmler‐Behnke, Alexander Wenk, Jana Burkhardt, Achim Aigner, Wolfgang G. Kreyling	18
5	Biokinetic datasets of PEI F25-LMW complexed and non-complexed 32P-siRNA within different lung compartments 2016 ·Data in Brief ·Jens Lipka, Manuela Semmler‐Behnke, Alexander Wenk, Jana Burkhardt, Achim Aigner, Wolfgang G. Kreyling	2
6	Size dependent translocation and fetal accumulation of gold nanoparticles from maternal blood in the rat 2014 ·Particle and Fibre Toxicology ·Manuela Semmler‐Behnke, Jens Lipka, Alexander Wenk, Stephanie Hirn, Martin Schäffler, Furong Tian, Günter Schmid, Günter Oberdörster, Wolfgang G. Kreyling	101
7	Air–Blood Barrier Translocation of Tracheally Instilled Gold Nanoparticles Inversely Depends on Particle Size 2013 ·ACS Nano ·Wolfgang G. Kreyling, Stephanie Hirn, Winfried Möller, Carsten Schleh, Alexander Wenk, (unknown), Jens Lipka, Martin Schäffler, Nadine Haberl, Blair D. Johnston, Ralph A. Sperling, Günter Schmid, Ulrich Simon, Wolfgang J. Parak, Manuela Semmler‐Behnke	199
8	Particle size-dependent and surface charge-dependent biodistribution of gold nanoparticles after intravenous administration breakdown → 2011 ·European Journal of Pharmaceutics and Biopharmaceutics ·Stephanie Hirn, Manuela Semmler‐Behnke, Carsten Schleh, Alexander Wenk, Jens Lipka, Martin Schäffler, Shinji Takenaka, Winfried Möller, Günter Schmid, Ulrich Simon, Wolfgang G. Kreyling	473
9	Size and surface charge of gold nanoparticles determine absorption across intestinal barriers and accumulation in secondary target organs after oral administration 2011 ·Nanotoxicology ·Carsten Schleh, Manuela Semmler‐Behnke, Jens Lipka, Alexander Wenk, Stephanie Hirn, Martin Schäffler, Günter Schmid, Ulrich Simon, Wolfgang G. Kreyling	268
10	Polyethylenimines for RNAi-mediated gene targeting in vivo and siRNA delivery to the lung 2010 ·European Journal of Pharmaceutics and Biopharmaceutics ·(unknown), Jens Lipka, Anastasia Malek, (unknown), Wolfgang G. Kreyling, Achim Aigner	144
11	Biodistribution of PEG-modified gold nanoparticles following intratracheal instillation and intravenous injection 2010 ·Biomaterials ·Jens Lipka, Manuela Semmler‐Behnke, Ralph A. Sperling, Alexander Wenk, Shinji Takenaka, Carsten Schleh, Thomas Kissel, Wolfgang J. Parak, Wolfgang G. Kreyling	421
12	Dosimetry and toxicology of inhaled ultrafine particles 2009 ·Biomarkers ·Otmar Schmid, Winfried Möller, Manuela Semmler‐Behnke, G.A. Ferron, Erwin Karg, Jens Lipka, Holger Schulz, Wolfgang G. Kreyling, Tobias Stoeger	143
13	Biodistribution of 1.4‐ and 18‐nm Gold Particles in Rats 2008 ·Small ·Manuela Semmler‐Behnke, Wolfgang G. Kreyling, Jens Lipka, (unknown), Alexander Wenk, Shinji Takenaka, Günter Schmid, Wolfgang Brandau	414

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact